Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$6,227,441
+$1,656,185 QoQ
Shares Held
5,192
+4.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,553
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHYSICIANS FINANCIAL SERVICES, INC. holds $25,900,793 across 8 Drug Manufacturers - General names. LLY ranks #1 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,192 | $6,227,441 | |
| 2 | AMGN |
Amgen Inc
|
16,942 | $6,135,037 | |
| 3 | JNJ |
Johnson & Johnson
|
23,841 | $6,054,898 | |
| 4 | ABBV |
AbbVie Inc.
|
12,050 | $3,032,262 | |
| 5 | NVS |
Novartis AG
|
12,234 | $1,917,312 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,970 | $1,409,645 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,692 | $788,933 | |
| 8 | PFE |
Pfizer Inc
|
13,923 | $335,265 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,227,441 | 5,192 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $4,571,256 | 4,970 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,404,039 | 4,098 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,048,948 | 3,996 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,051,859 | 3,915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,979,057 | 3,607 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,344,564 | 3,037 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,683,512 | 3,029 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,593,008 | 2,864 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,188,401 | 2,813 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,604,778 | 2,753 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,465,290 | 2,728 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,274,687 | 2,718 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $916,244 | 2,668 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $976,061 | 2,668 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $862,697 | 2,668 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $865,045 | 2,668 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $764,035 | 2,668 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $736,954 | 2,668 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $616,441 | 2,668 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $612,359 | 2,668 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $542,712 | 2,905 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $467,349 | 2,768 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $409,719 | 2,768 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $454,450 | 2,768 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $383,976 | 2,768 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||